Pretreatment eosinophilia in NSCLC patients is associated with increased immune-related adverse events and reduced progression-free survival when treated with ICIs. The review included 11 ...
Gray hair in mice signals successful elimination of cancer-prone stem cells. Study offers clues about melanoma risk in humans ...
Prime Minister Sanae Takaichi isn't shying away from the hot button issue of Taiwan that her predecessors tread lightly on, ...
Long-acting injectables (LAIs) were designed to solve this problem by reducing the burden of daily pill-taking and ensuring more consistent drug exposure. Underutilization of LAIs in the U.S is common ...
Akeso, Inc. (HKEX: 9926.HK) is excited to announce that the final Overall Survival (OS) analysis results from the HARMONi-A study, a Phase III study evaluating ivonescimab combined with chemotherapy ...
Gender has been long overlooked in Holocaust research. Writing in the late 1970s and early 1980s, early scholars such as Joan Ringelheim and Sybil Milton had to fight for their legitimacy in a field ...
Altcoin traders use 8-step plan to manage risk, with 72% of top coins down 50%. Here are survival strategies for altcoin ...
Sudan’s violent armed conflict, now entering its third year, has contaminated pastures in key agricultural regions with ...
CABI scientists, who have published their research in the journal CABI Agriculture and Bioscience, suggest that an ...
The findings suggest that the HER2DX assay could help clinicians decide on the appropriate use of chemotherapy in older patients, study researchers wrote.
By analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce ...
“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results